FI62666C - Foerfarande foer framstaellning av terapeutiskt aktivt 6-klor-2-(1'-piperazinyl)pyrazin och salter daerav - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktivt 6-klor-2-(1'-piperazinyl)pyrazin och salter daerav Download PDF

Info

Publication number
FI62666C
FI62666C FI760978A FI760978A FI62666C FI 62666 C FI62666 C FI 62666C FI 760978 A FI760978 A FI 760978A FI 760978 A FI760978 A FI 760978A FI 62666 C FI62666 C FI 62666C
Authority
FI
Finland
Prior art keywords
formula
chloro
compound
piperazinyl
pyrazine
Prior art date
Application number
FI760978A
Other languages
English (en)
Finnish (fi)
Other versions
FI62666B (fi
FI760978A (es
Inventor
Walfred Spencer Saari
Jr William Carl Lumma
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI760978A publication Critical patent/FI760978A/fi
Publication of FI62666B publication Critical patent/FI62666B/fi
Application granted granted Critical
Publication of FI62666C publication Critical patent/FI62666C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI760978A 1975-04-21 1976-04-09 Foerfarande foer framstaellning av terapeutiskt aktivt 6-klor-2-(1'-piperazinyl)pyrazin och salter daerav FI62666C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57005275A 1975-04-21 1975-04-21
US57005275 1975-04-21

Publications (3)

Publication Number Publication Date
FI760978A FI760978A (es) 1976-10-22
FI62666B FI62666B (fi) 1982-10-29
FI62666C true FI62666C (fi) 1983-02-10

Family

ID=24277994

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760978A FI62666C (fi) 1975-04-21 1976-04-09 Foerfarande foer framstaellning av terapeutiskt aktivt 6-klor-2-(1'-piperazinyl)pyrazin och salter daerav

Country Status (36)

Country Link
JP (1) JPS51136688A (es)
AR (1) AR210349A1 (es)
AT (1) AT353795B (es)
AU (1) AU496854B2 (es)
BE (1) BE840904A (es)
BG (1) BG34185A3 (es)
CA (1) CA1059128A (es)
CH (1) CH619462A5 (es)
CS (1) CS195726B2 (es)
CY (1) CY1090A (es)
DD (1) DD124599A5 (es)
DE (1) DE2617205C3 (es)
DK (1) DK143899C (es)
EG (1) EG12387A (es)
ES (4) ES447150A1 (es)
FI (1) FI62666C (es)
FR (1) FR2308367A1 (es)
GB (1) GB1492528A (es)
GR (1) GR59900B (es)
HK (1) HK60380A (es)
HU (1) HU172684B (es)
IE (1) IE42979B1 (es)
IL (1) IL49391A (es)
KE (1) KE3088A (es)
LU (1) LU74795A1 (es)
MY (1) MY8100225A (es)
NL (1) NL167692C (es)
NO (1) NO146599C (es)
PH (1) PH12274A (es)
PL (1) PL99664B1 (es)
PT (1) PT65027B (es)
RO (1) RO73278A (es)
SE (1) SE421695B (es)
SU (1) SU638260A3 (es)
YU (1) YU100676A (es)
ZA (1) ZA762320B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
US4163849A (en) 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
US4252816A (en) * 1979-12-03 1981-02-24 Merck & Co., Inc. Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents
US4339579A (en) 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
EP0094498A3 (en) * 1982-05-06 1985-04-03 American Cyanamid Company Antiatherosclerotic 1-piperazine derivatives
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
EP0580465A1 (fr) * 1992-06-25 1994-01-26 Sanofi Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
AU773830B2 (en) * 1999-04-26 2004-06-10 Neurosearch A/S Heteroaryl diazacycloalkanes, their preparation and use
KR20030031886A (ko) * 2000-02-16 2003-04-23 뉴로젠 코포레이션 치환된 아릴피라진
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
SE0202287D0 (sv) * 2002-07-19 2002-07-19 Biovitrum Ab New compounds
ATE353693T1 (de) 2002-07-19 2007-03-15 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606906A (en) * 1948-10-14 1952-08-12 American Cyanamid Co 1-(2-pyridyl) piperazine and process of preparing same

Also Published As

Publication number Publication date
CS195726B2 (en) 1980-02-29
FR2308367A1 (fr) 1976-11-19
RO73278A (ro) 1982-09-09
AU1296676A (en) 1977-10-20
HK60380A (en) 1980-11-07
DE2617205C3 (de) 1981-01-29
AR210349A1 (es) 1977-07-29
HU172684B (hu) 1978-11-28
IE42979L (en) 1976-10-21
NL7603800A (nl) 1976-10-25
KE3088A (en) 1980-11-07
SU638260A3 (ru) 1978-12-15
DD124599A5 (es) 1977-03-02
MY8100225A (en) 1981-12-31
GB1492528A (en) 1977-11-23
LU74795A1 (es) 1977-02-07
CY1090A (en) 1980-12-27
IL49391A0 (en) 1976-06-30
BE840904A (fr) 1976-08-16
CH619462A5 (en) 1980-09-30
ES459406A1 (es) 1978-08-16
DK164476A (da) 1976-10-22
ES459407A1 (es) 1978-08-16
ES447150A1 (es) 1977-09-16
EG12387A (en) 1978-12-31
BG34185A3 (en) 1983-07-15
PH12274A (en) 1978-12-12
DE2617205A1 (de) 1976-10-28
AT353795B (de) 1979-12-10
DK143899C (da) 1982-04-13
DK143899B (da) 1981-10-26
NL167692C (nl) 1982-01-18
SE7604093L (sv) 1976-10-22
AU496854B2 (en) 1978-11-02
ATA288376A (de) 1979-05-15
NO146599B (no) 1982-07-26
FI62666B (fi) 1982-10-29
FR2308367B1 (es) 1979-09-21
YU100676A (en) 1982-08-31
ES459405A1 (es) 1978-08-16
PT65027A (en) 1976-05-01
CA1059128A (en) 1979-07-24
GR59900B (en) 1978-03-16
NO761207L (es) 1976-10-22
JPS5522475B2 (es) 1980-06-17
JPS51136688A (en) 1976-11-26
PL99664B1 (pl) 1978-07-31
NO146599C (no) 1982-11-03
ZA762320B (en) 1977-11-30
NL167692B (nl) 1981-08-17
SE421695B (sv) 1982-01-25
FI760978A (es) 1976-10-22
DE2617205B2 (de) 1980-05-08
PT65027B (en) 1978-04-03
IE42979B1 (en) 1980-11-19
IL49391A (en) 1979-09-30

Similar Documents

Publication Publication Date Title
FI62666C (fi) Foerfarande foer framstaellning av terapeutiskt aktivt 6-klor-2-(1'-piperazinyl)pyrazin och salter daerav
US7579365B2 (en) Indolyl-3-glyoxylic acid derivatives having antitumor action
US3696197A (en) Pharmaceutical compositions containing homopyrimidazole derivatives
EP0079545B1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
HU184989B (en) Process for preparing derivatives of 2-/4-/diphenyl-methyl/-piperazin-1-yl/-acetic acid
HU211256A9 (en) New benzimidazolone derivatives
JPH0735371B2 (ja) 新規なオキサゾロピリジン誘導体、これらの製造法およびそれらを含む製薬組成物
JP2002504103A (ja) ３−置換された３、４−ジヒドロチエノ［２、３−ｄ］ピリミジン誘導体
US3944551A (en) N-Coumaranyl and chromanyl -methyl-or sulfur analogs thereof-N'- thiazolyl piperazines
HU190635B (en) Process for preparing benzoxazoline-derivatives and the pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions comprising the same as active substance
FI94953B (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
HU201057B (en) Process for producing 6-phenyl-3-(piperazinyl-alkyl)-1h,3h-pyrimidin-2,4-dion derivatives and pharmaceutical compositions containing them
FI77456C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 3-/2-/4-(2-metoxifenyl) -1-piperazinyl/etyl/-2,4-(1h,3h)-kinazolindionderivat.
CS274494B2 (en) Method of substituted styrene derivatives preparation
US4065451A (en) 1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts
EP3277687B1 (en) 7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives which are useful for the treatment of immune or inflammatory diseases or cancer
ES2215312T3 (es) Derivados de pirido(3',4':4,5)tieno(2,3-d)-pirimidina 3-substituidos, su obtencion y empleo.
US4022779A (en) Amino derivatives of pyrido(3,4-b)pyrazine carboxylic acids and esters
HU196998B (en) Process for producing basically substituted pyridine derivatives and pharmaceuticals comprising same
KR790001500B1 (ko) 피페라지닐 피라진 화합물의 제법
US3838122A (en) 2-heterocyclic-1,3-benzodiazepines
FI82048B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tetraoxo-3,7-diazabicyklo (3,3,1)- nonanderivat.
DE2361757A1 (de) Neue imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine
JPH1017555A (ja) ６−アミノ−５−メチルウラシル誘導体

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MERCK & CO INC.